The purpose of this study is to assess the supportive role of an investigational dietary supplement when taken by subjects who are also taking previously failed antibiotics to treat an uncomplicated, community-acquired skin infections, including infections due to Methicillin-Resistant staphylococcus aureus (MRSA).
Duration: Approximately 30 days
Number of visits to AMR Lexington: 5
Compensation is available for time and travel.
Qualified participants must be between the ages of 18 and 75 years old, be taking antibiotics as prescribed by a physician to treat an uncomplicated skin infection, and be in general good health. Other criteria also apply.